Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Since the COVID-19 pandemic, One Health approaches1 have revived attention to the interdependence of human, animal, and ecosystem health. However, human health is still predominantly viewed through ...

Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work ...

Regulators will soon “unleash a massive framework” for how vaccines are tested and approved, according to FDA Commissioner ...

Amid a deluge of cuts to federal spending, the Trump administration has canceled three grants totaling $85.6 million to Santa Clara County that helped fund public health initiatives related to the ...

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

In other vaccine news, Health Secretary Robert F. Kennedy Jr. has officially ordered placebo testing on new vaccines, a change that experts claim will be costly and — harkening back to polio vaccine ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

The variant JN.1 was first detected in 2023 which led to increase in COVID-19 cases in Asian countries like Singapore, China, ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...